Word

2 PA PA-FORMULA

Status

Dead

Status Code

710

Status Date

Friday, December 1, 2023

Serial Number

86771138

Registration Number

5205592

Registration Date

Tuesday, May 16, 2017

Mark Type

5000

Filing Date

Monday, September 28, 2015

Published for Opposition

Tuesday, October 11, 2016

Cancellation Date

Friday, December 1, 2023

Trademark Owner History

GOLDEN BIOTECHNOLOGY CORPORATION - Original Registrant

Classifications

5 Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional food additives for medical purposes for human consumption or animals in the nature of natural food extracts derived from soybean; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases

The mark consists of the wording "PA PA-FORMULA" with the letters "PA PA-" in blue and "FORMULA" in green and with "PA PA" floating on top of the number "2" in light blue.
The color(s) green, light blue and blue is/are claimed as a feature of the mark.

Trademark Events

Dec 1, 2023

Cancelled Sec. 8 (6-Yr)

May 16, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

May 16, 2017

Registered-Principal Register

Apr 11, 2017

Notice Of Acceptance Of Statement Of Use E-Mailed

Apr 10, 2017

Allowed Principal Register - Sou Accepted

Apr 8, 2017

Statement Of Use Processing Complete

Mar 28, 2017

Use Amendment Filed

Apr 7, 2017

Case Assigned To Intent To Use Paralegal

Mar 28, 2017

Teas Statement Of Use Received

Dec 6, 2016

Noa E-Mailed - Sou Required From Applicant

Oct 11, 2016

Official Gazette Publication Confirmation E-Mailed

Oct 11, 2016

Published For Opposition

Sep 21, 2016

Notification Of Notice Of Publication E-Mailed

Sep 6, 2016

Law Office Publication Review Completed

Sep 6, 2016

Approved For Pub - Principal Register

Sep 2, 2016

Teas/Email Correspondence Entered

Sep 1, 2016

Correspondence Received In Law Office

Sep 1, 2016

Teas Response To Office Action Received

Jun 14, 2016

Notification Of Non-Final Action E-Mailed

Jun 14, 2016

Non-Final Action E-Mailed

Jun 14, 2016

Non-Final Action Written

Jun 14, 2016

Previous Allowance Count Withdrawn

Jun 7, 2016

Withdrawn From Pub - Og Review Query

May 25, 2016

Law Office Publication Review Completed

May 23, 2016

Approved For Pub - Principal Register

May 23, 2016

Teas/Email Correspondence Entered

May 23, 2016

Correspondence Received In Law Office

May 23, 2016

Teas Request For Reconsideration Received

May 19, 2016

Notification Of Final Refusal Emailed

May 19, 2016

Final Refusal E-Mailed

May 19, 2016

Final Refusal Written

May 19, 2016

Teas/Email Correspondence Entered

May 19, 2016

Correspondence Received In Law Office

May 12, 2016

Assigned To Lie

May 2, 2016

Teas Response To Office Action Received

Feb 22, 2016

Teas Change Of Correspondence Received

Jan 15, 2016

Notification Of Non-Final Action E-Mailed

Jan 15, 2016

Non-Final Action E-Mailed

Jan 15, 2016

Non-Final Action Written

Jan 15, 2016

Assigned To Examiner

Oct 2, 2015

New Application Office Supplied Data Entered

Oct 1, 2015

New Application Entered